ERBB2 and neoplasm: Consequently, forthcoming research will focus on integrating surface functionalization using folate, or HER2 ligands and biodegradable polymeric coatings, chitosan, to improve active tumor targeting, regulate drug release, and facilitate renal clearance [35].